Has John Vukich, MD received payments from drug or device companies?

Yes. Drug and device makers reported $356,127 in general payments to John Vukich, MD across 147 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean John Vukich, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about John Vukich, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

John Vukich, MD

Ophthalmology · Wauwatosa, WINPI 1124065537

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $315,244 of the $356,127 with a category attached, or 88.5%. Rxsight Inc accounts for 60.7% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2022 at $154,589 and has fallen 75.2% since, to $38,284 in 2025. Among ophthalmology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$356,127in general payments, 2019–2025

Across 147 payments — averaging $2422.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Rxsight Inc$216K
Clerio Vision, Inc$49K
Johnson & Johnson Surgical Vision, Inc.$42K
Bausch & Lomb Americas Inc.$30K
Lensar, Inc.$12K
Glaukos Corporation$5K
plus $2K from 11 others

$198,460in research payments, 2019–2025

Across 34 payments — averaging $5837.06 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Rxsight Inc$114K
Bausch & Lomb Americas Inc.$75K
Carl Zeiss Meditec Production LLC$9K
Alcon Research LLC$600

What the payments were for

Consulting fees$315,24489%
Speaking & faculty fees$20,2826%
Travel & lodging$4,6241%
Food & beverage$8,7202%
Education$800%
Gifts$7,1772%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Rxsight Inc	42	$216,290
Clerio Vision, Inc	3	$48,731
Johnson & Johnson Surgical Vision, Inc.	33	$42,322
Bausch & Lomb Americas Inc.	23	$29,951
Lensar, Inc.	9	$11,600
Glaukos Corporation	2	$5,063
Carl Zeiss Meditec, Inc.	4	$396
Beaver-visitec International, Inc.	2	$375
Alcon	3	$349
Carl Zeiss Meditec USA, Inc.	3	$233
AbbVie(2 entities)	10	$204
Alcon Research LLC	2	$175
The Cameron-ehlen Group, Inc.	4	$138
Novartis	1	$116
Rayner Intraocular Lenses Limited	4	$89
Staar Surgical Company	1	$82
Lumibird Medical Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD)$153,725
RXSIGHT INJECTOR HANDPIECE$62,239
RXSIGHT CONTACT LENS$62,239
RXSIGHT INJECTOR CARTRIDGE$62,239
RXSIGHT LIGHT DELIVERY DEVICE (LDD)$62,239
LIGHT ADJUSTABLE LENS (LAL)$36,651
Tecnis Symfony IOL$30,244
EXTREME H20$26,731
Tecnis Symfony Toric IOL$26,475
RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$25,588
IC-8 Apthera IOL$24,669
Lenses$22,000
enVista MX60 IOL$16,644
STELLARIS ELITE$16,644
LENSAR LASER SYSTEM$11,494
Tecnis Multifocal Family of 1-piece IOLS$9,838
Catalys Laser System$9,530
COMPACT INTUITIV Phacofragmentation System$7,800
iStent Infinite$5,000
Travoprost Intraocular Implant - iDose$5,000

How this compares

$356,127 in reported general payments places this provider in the 95th percentile of 337 ophthalmology providers in Wisconsin.

See all ophthalmology providers in Wisconsin →

Medicare billing

Part B allowed, 2024

$218,662

Medicare patients

307

Services billed

1,043

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Prednisolone Acetate	74	$2,334
Ketorolac Tromethamine	62	$1,664
Latanoprost	25	$239
Timolol Maleate	11	$226
Ofloxacin	15	$145

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Wauwatosa

Inder SinghRacine$2.5M
Deepak SambharaWausau$388K
Eugene EldridgeKenosha$294K
Michael ShapiroMadison$71K
Douglas SalmAppleton$38K
Julia AgapovMadison$26K
Thomas HarveyChippewa Falls$23K
Michael VrabecAppleton$20K
Philip SmithMinocqua$18K
Syed Shahla Crosse$16K

See the full list for Wisconsin →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →